First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
about
Recent advances in acute promyelocytic leukaemia.Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags.Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
P2860
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
First experience of the AML-Be ...... e and all-trans retinoid acid.
@en
First experience of the AML-Be ...... e and all-trans retinoid acid.
@nl
type
label
First experience of the AML-Be ...... e and all-trans retinoid acid.
@en
First experience of the AML-Be ...... e and all-trans retinoid acid.
@nl
prefLabel
First experience of the AML-Be ...... e and all-trans retinoid acid.
@en
First experience of the AML-Be ...... e and all-trans retinoid acid.
@nl
P2093
P2860
P356
P1476
First experience of the AML-Be ...... e and all-trans retinoid acid.
@en
P2093
Christian Flotho
Christine von Neuhoff
Claudia Rossig
Dirk Reinhardt
Irene Schmid
Jans-Enno Mueller
Jörg Faber
Konrad Bochennek
Michael N Dworzak
Nils von Neuhoff
P2860
P356
10.1002/PBC.26461
P577
2017-01-23T00:00:00Z